Literature DB >> 15507635

Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.

Mark Trottier1, Brian P Schlitt, Aisha Y Kung, Howard L Lipton.   

Abstract

The dynamics of Theiler's murine encephalomyelitis virus (TMEV) RNA replication in the central nervous systems of susceptible and resistant strains of mice were examined by quantitative real-time reverse transcription-PCR and were found to correlate with host immune responses. During the acute phase of infection in both susceptible and resistant mice, levels of viral replication were high in the brain and brain stem, while levels of viral genome equivalents were 10- to 100-fold lower in the spinal cord. In the brain, viral RNA replication decreased after a peak at 5 days postinfection (p.i.), in parallel with the appearance of virus-specific antibody responses; however, by 15 days p.i., viral RNA levels began to increase in the spinal cords of susceptible mice. During the transition to and the persistent phase of infection, the numbers of viral genome equivalents in the spinal cord varied substantially for individual mice, but high levels were consistently associated with high levels of proinflammatory Th1 cytokine and chemokine mRNAs. Moreover, a large number of viral genome equivalents and high proinflammatory cytokine mRNA levels in spinal cords were only observed for susceptible SJL/J mice who developed demyelinating disease. These results suggest that TMEV persistence requires active viral replication beginning about day 11 p.i. and that active viral replication with high viral genome loads leads to increased levels of Th1 cytokines that drive disease progression in infected mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507635      PMCID: PMC525090          DOI: 10.1128/JVI.78.22.12480-12488.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis.

Authors:  M L Jelachich; H L Lipton
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

2.  An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.

Authors:  S Dethlefs; M Brahic; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 3.  Genetics of susceptibility to Theiler's virus infection.

Authors:  M Brahic; J F Bureau
Journal:  Bioessays       Date:  1998-08       Impact factor: 4.345

4.  Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

Authors:  W S Begolka; C L Vanderlugt; S M Rahbe; S D Miller
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

5.  The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.

Authors:  M K Njenga; K Asakura; S F Hunter; P Wettstein; L R Pease; M Rodriguez
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice.

Authors:  S Dethlefs; N Escriou; M Brahic; S van der Werf; E L Larsson-Sciard
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue.

Authors:  N D Borson; C Paul; X Lin; W K Nevala; M A Strausbauch; M Rodriguez; P J Wettstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS.

Authors:  Katherine L Neville; Josette Padilla; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2002-02       Impact factor: 3.478

Review 9.  Interleukin 6 and its receptor: ten years later.

Authors:  T Hirano
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

10.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.

Authors:  S D Miller; C L Vanderlugt; W S Begolka; W Pao; R L Yauch; K L Neville; Y Katz-Levy; A Carrizosa; B S Kim
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

View more
  17 in total

1.  Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release.

Authors:  E G Vichaya; E E Young; M A Frazier; J L Cook; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2011-10-13       Impact factor: 3.478

2.  Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence.

Authors:  Stephane Steurbaut; Bart Rombaut; Raf Vrijsen
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  An in vitro experimental model of neuroinflammation: the induction of interleukin-6 in murine astrocytes infected with Theiler's murine encephalomyelitis virus, and its inhibition by oestrogenic receptor modulators.

Authors:  Nazario Rubio; Marie Cerciat; Mikko Unkila; Luis M Garcia-Segura; Maria-Angeles Arevalo
Journal:  Immunology       Date:  2011-05-13       Impact factor: 7.397

4.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

5.  Survivin prevents apoptosis by binding to caspase-3 in astrocytes infected with the BeAn strain of Theiler's murine encephalomyelitis virus.

Authors:  Nazario Rubio; Luis Miguel Garcia-Segura; Maria-Angeles Arevalo
Journal:  J Neurovirol       Date:  2012-05-26       Impact factor: 2.643

6.  Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection.

Authors:  Mark D Trottier; Douglas S Lyles; Carol Shoshkes Reiss
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

7.  The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System.

Authors:  Martin P Hosking; Thomas E Lane
Journal:  Curr Immunol Rev       Date:  2009-05-04

8.  Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.

Authors:  Jingshan Zhang; Howard L Lipton; Alan S Perelson; Harel Dahari
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

9.  Overexpression of caspase 1 in apoptosis-resistant astrocytes infected with the BeAn Theiler's virus.

Authors:  Nazario Rubio; Francisco Sanz-Rodriguez
Journal:  J Neurovirol       Date:  2015-11-13       Impact factor: 2.643

10.  Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection.

Authors:  Wanqiu Hou; Hyun Seok Kang; Byung S Kim
Journal:  J Exp Med       Date:  2009-02-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.